Jason Cole, Chief Strategy and Financial Officer, to Depart bluebird bio This Fall
(NASDAQ: BLUE) today announced that Jason Cole, Chief Strategy and Financial Officer, plans to leave bluebird bio to pursue new career opportunities.
- (NASDAQ: BLUE) today announced that Jason Cole, Chief Strategy and Financial Officer, plans to leave bluebird bio to pursue new career opportunities.
- Throughout his 8.5 years at bluebird, Mr. Cole has held multiple roles including General Counsel/Chief Legal Officer (2014-2019), Chief Operating & Legal Officer (2019-2021) and Chief Business Officer (2021-2022).
- In March 2022, Mr. Cole was appointed Chief Strategy and Financial Officer at a critical juncture for the company.
- Jason is the quintessential bluebird with a deep commitment to the patients and families we aspire to treat, to our business, and to the culture that makes bluebird so unique, said Andrew Obenshain, CEO, bluebird bio.